|
SourceBio International PLC - Nottingham-based laboratory services provider - Records a pretax profit of £20.7 million in 2021, up sharply from £2.8 million in 2020. This was on revenue growth of 82% to £92.4 million from 50.7 million. Credits these record results to the provision of Covid-19 PCR testing services and a recovery from the Covid-19 pandemic in its core units. Plans to implement a share buyback programme. Says trading in the early months of 2022 has been solid and in line with expectations. Believes it is well-positioned to deliver further attractive growth in revenue and margin from its core businesses in 2022.
Current stock price: 123.75 pence, up 7.6% on Tuesday
12-month change: down 31%
Copyright 2022 Alliance News Limited. All Rights Reserved.
|
